SOUTHWEST ONCOLOGY GROUP CA-13612

西南肿瘤学组 CA-13612

• 批准号: 6856680
• 负责人: THOMAS Patrick MILLER
• 金额: $ 11.92万
• 依托单位: UNIVERSITY OF ARIZONA
• 依托单位国家: 美国
• 财政年份: 1978
• 资助国家: 美国
• 起止时间: 1978-01-01 至 2004-03-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6856680
• 关键词: antineoplastics; bleomycin; bone marrow transplantation; brain neoplasms; breast neoplasms; cancer information system; cancer prevention; cancer registry /resource; cis platinum compound; clinical research; clinical trials; combination cancer therapy; combination chemotherapy; cooperative study; cyclophosphamide; doxorubicin; drug resistance; female reproductive system neoplasm; fludarabine; gastrointestinal neoplasms; head /neck neoplasm; hormone therapy; human subject; human therapy evaluation; ifosfamide; leukemia; lung neoplasms; lymphoma; meeting /conference /symposium; melanoma; multiple myeloma; neoplasm /cancer chemotherapy; neoplasm /cancer diagnosis; neoplasm /cancer epidemiology; neoplasm /cancer genetics; neoplasm /cancer immunotherapy; neoplasm /cancer radiation therapy; neoplasm /cancer surgery; oncology nursing; paclitaxel; pancreas neoplasms; pathology; prognosis; prostate neoplasms; quality of life; sarcoma; tamoxifen; tissue resource /registry; urinary tract neoplasms; women' s health

Description: Funding is requested to support the Arizona Cancer Center (University of Arizona) participation in Southwest Oncology Group cooperative cancer clinical research to improve the treatment of cancer in humans. Specific aims and objectives are: 1. To continue to meet current scientific leadership and core service commitments including: (A) protocol coordination (multiple studies); (B) disease/discipline committee administration; (C) reference and repository laboratory administration; and (D) group quality assurance and quality control. 2. To continue to promote the rapid integration of promising new research leads, including those developed at the Arizona Cancer Center, into cooperative group testing to improve patient treatment options and patient care. 3. To continue to meet institutional clinical research commitments in the recruitment of appropriate patients for SWOG studies and all attendant commitments to long-term follow up, quality control, etc. 4. To continue to promote community physician and patient awareness and participation in SWOG clinical trials by continued support of the Cooperative Group Outreach Program (CGOP) and other outreach and continuing education programs and activities. 5. To continue efforts to understand factors affecting accrual, particularly those in special populations (e.g., minority, elderly, financially disadvantaged), and to implement appropriate interventions where possible.

描述：请求资助亚利桑那州癌症中心 （亚利桑那大学）参与西南肿瘤学小组 合作癌症临床研究以改善癌症治疗 人类 具体目标和目的是： 1. 继续满足当前的科学领导和核心服务 承诺包括：（A）方案协调（多项研究）;（B） 疾病/学科委员会管理;（C）参考和储存库 实验室管理;以及（D）小组质量保证和质量 控制 2. 继续促进有前途的新研究的快速整合 包括亚利桑那州癌症中心开发的线索， 合作小组测试，以改善患者的治疗选择和患者 在乎 3. 继续履行机构临床研究承诺， 为SWOG研究招募合适的患者， 承诺长期跟踪、质量控制等。 4. 继续提高社区医生和病人的认识， 参与SWOG临床试验， 合作小组外联方案和其他外联活动， 教育计划和活动。 5. 继续努力了解影响应计制的因素， 特别是那些特殊人群（例如，少数民族，老年人， 经济上处于不利地位），并在下列情况下实施适当的干预措施： 可能